EPHA2 and neoplasm: Although we found decreased lymphocyte populations in lungs bearing EphA2-overexpressing tumors, this result may be confounded by the substantially higher tumor burden in these lungs, compared to the controls, which contained less than a percentage of KPL tumor cells.